Autopsy report · NCT00562601

LCI Apheresis to Obtain Plasma or White Blood Cells

“Closed by the Sponsor/DSMB/IRB”

The sponsor’s own words in the registry.

Life of this trial

• Registered 19 years 8 months after it had already started.
• Ran for about 31 years 10 months before it stopped.
• 864 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Sponsor type

US National Institutes of Health

Conditions

Apheresis

Participants

864

Sites

1

Countries

United States

Trials that died the same way

• Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
  “Closed by sponsor” (80% match in meaning)
• Leptin in Human Energy and Neuroendocrine Homeostasis
  “Closed by sponsor. Lack of funding.” (72% match in meaning)
• Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
  “DSMB closed due to futility.” (67% match in meaning)
• Dexmedetomidine Cycling and Sleep in the Pediatric ICU
  “No enrollment, IRB closed” (65% match in meaning)
• Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
  “Closed by sponsor, lack of enrollment.” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.